{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:01:34Z","timestamp":1790416894958,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"crossref","award":["28-6"],"award-info":[{"award-number":["28-6"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"crossref","award":["2019B4"],"award-info":[{"award-number":["2019B4"]}],"id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ek0109373h0003"],"award-info":[{"award-number":["20ek0109373h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Growth Science"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Silver-Russell syndrome (SRS) is characterized by growth failure and dysmorphic features. Major (epi)genetic causes of SRS are loss of methylation on chromosome 11p15 (11p15 LOM) and maternal uniparental disomy of chromosome 7 (upd(7)mat). However,\n                      <jats:italic>IGF2<\/jats:italic>\n                      ,\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      ,\n                      <jats:italic>HMGA2<\/jats:italic>\n                      , and\n                      <jats:italic>PLAG1<\/jats:italic>\n                      mutations infrequently cause SRS. In addition, other imprinting disturbances, pathogenic copy number variations (PCNVs), and monogenic disorders sometimes lead to SRS phenotype. This study aimed to clarify the frequency and clinical features of the patients with gene mutations among etiology-unknown patients with SRS phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multigene sequencing was performed in 92 out of 336 patients referred to us for genetic testing for SRS. The clinical features of the patients were evaluated based on the Netchine-Harbison clinical scoring system. None of the patients showed 11p15 LOM, upd(7)mat, abnormal methylation levels for six differentially methylated regions (DMRs), namely,\n                      <jats:italic>PLAGL1<\/jats:italic>\n                      :alt-TSS-DMR on chromosome 6,\n                      <jats:italic>KCNQ1OT1<\/jats:italic>\n                      :TSS-DMR on chromosome 11,\n                      <jats:italic>MEG3\/DLK1<\/jats:italic>\n                      :IG-DMR on chromosome 14,\n                      <jats:italic>MEG3<\/jats:italic>\n                      :TSS-DMR on chromosome 14,\n                      <jats:italic>SNURF<\/jats:italic>\n                      :TSS\n                      <jats:italic>-<\/jats:italic>\n                      DMR on chromosome 15, and\n                      <jats:italic>GNAS A\/B<\/jats:italic>\n                      :TSS-DMR on chromosome 20, PCNVs, or maternal uniparental disomy of chromosome 16. Using next-generation sequencing and Sanger sequencing, we screened four SRS-causative genes and 406 genes related to growth failure and\/or skeletal dysplasia. We identified four pathogenic or likely pathogenic variants in responsible genes for SRS (4.3%:\n                      <jats:italic>IGF2<\/jats:italic>\n                      in two patients,\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      , and\n                      <jats:italic>PLAG1<\/jats:italic>\n                      ), and five pathogenic variants in causative genes for known genetic syndromes presenting with growth failure (5.4%:\n                      <jats:italic>IGF1R<\/jats:italic>\n                      abnormality (\n                      <jats:italic>IGF1R<\/jats:italic>\n                      ), SHORT syndrome (\n                      <jats:italic>PIK3R1<\/jats:italic>\n                      ), Floating-Harbor syndrome (\n                      <jats:italic>SRCAP<\/jats:italic>\n                      ), Pitt-Hopkins syndrome (\n                      <jats:italic>TCF4<\/jats:italic>\n                      ), and Noonan syndrome (\n                      <jats:italic>PTPN11<\/jats:italic>\n                      )). Functional analysis indicated the pathogenicity of the\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      variant. The variants we detected in\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      and\n                      <jats:italic>PLAG1<\/jats:italic>\n                      were the second and third variants leading to SRS, respectively. Our patients with\n                      <jats:italic>CDKN1C<\/jats:italic>\n                      and\n                      <jats:italic>PLAG1<\/jats:italic>\n                      variants showed similar phenotypes to previously reported patients. Furthermore, our data confirmed\n                      <jats:italic>IGF1R<\/jats:italic>\n                      abnormality, SHORT syndrome, and Floating-Harbor syndrome are differential diagnoses of SRS because of the shared phenotypes among these syndromes and SRS. On the other hand, the patients with pathogenic variants in causative genes for Pitt-Hopkins syndrome and Noonan syndrome were atypical of these syndromes and showed partial clinical features of SRS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified nine patients (9.8%) with pathogenic or likely pathogenic variants out of 92 etiology-unknown patients with SRS phenotype. This study expands the molecular spectrum of SRS phenotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-020-00865-x","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T08:02:36Z","timestamp":1592294556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Contribution of gene mutations to Silver-Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Takanobu","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akie","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Iwahashi-Odano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Tanase-Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suzumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yamazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Fuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-455X","authenticated-orcid":false,"given":"Masayo","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"865_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrendo.2016.138","volume":"13","author":"EL Wakeling","year":"2017","unstructured":"Wakeling EL, Brioude F, Lokulo-Sodipe O, O'Connell SM, Salem J, Bliek J, et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017;13:105\u201324.","journal-title":"Nat Rev Endocrinol."},{"key":"865_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060105","volume":"8","author":"T Fuke","year":"2013","unstructured":"Fuke T, Mizuno S, Nagai T, Hasegawa T, Horikawa R, Miyoshi Y, et al. Molecular and clinical studies in 138 Japanese patients with Silver-Russell syndrome. PLoS One. 2013;8:e60105.","journal-title":"PLoS One."},{"key":"865_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/gim.2017.105","volume":"20","author":"W Abi Habib","year":"2018","unstructured":"Abi Habib W, Brioude F, Edouard T, Bennett JT, Lienhardt-Roussie A, Tixier F, et al. Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction. Genet Med. 2018;20:250\u20138.","journal-title":"Genet Med."},{"key":"865_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/jhg.2015.29","volume":"60","author":"A De Crescenzo","year":"2015","unstructured":"De Crescenzo A, Citro V, Freschi A, Sparago A, Palumbo O, Cubellis MV, et al. A splicing mutation of the HMGA2 gene is associated with Silver-Russell syndrome phenotype. J Hum Genet. 2015;60:287\u201393.","journal-title":"J Hum Genet."},{"key":"865_CR5","doi-asserted-by":"crossref","unstructured":"Inoue T, Nakamura A, Fuke T, Yamazawa K, Sano S, Matsubara K, et al. Genetic heterogeneity of patients with suspected Silver-Russell syndrome: genome-wide copy number analysis in 82\u00a0patients without imprinting defects. Clin Epigenetics. 2017;9:52.","DOI":"10.1186\/s13148-017-0350-6"},{"key":"865_CR6","doi-asserted-by":"crossref","unstructured":"Kagami M, Nagasaki K, Kosaki R, Horikawa R, Naiki Y, Saitoh S, et al. Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients. Genet Med. 2017;19:1356\u201366.","DOI":"10.1038\/gim.2017.53"},{"key":"865_CR7","doi-asserted-by":"crossref","unstructured":"Kawashima S, Nakamura A, Inoue T, Matsubara K, Horikawa R, Wakui K, et al. Maternal uniparental disomy for chromosome 20: physical and endocrinological characteristics of five patients. J Clin Endocrinol Metab. 2018;103:2083\u20138.","DOI":"10.1210\/jc.2017-02780"},{"key":"865_CR8","doi-asserted-by":"crossref","unstructured":"Yamazawa K, Nakabayashi K, Kagami M, Sato T, Saitoh S, Horikawa R, et al. Parthenogenetic chimaerism\/mosaicism with a Silver-Russell syndrome-like phenotype. J Med Genet.\u00a02010;47:782\u20135.","DOI":"10.1136\/jmg.2010.079343"},{"key":"865_CR9","doi-asserted-by":"crossref","unstructured":"Luk HM, Ivan Lo FM, Sano S, Matsubara K, Nakamura A. Ogata T, et al. Silver-Russell syndrome in a patient with somatic mosaicism for upd(11)mat identified by buccal cell analysis. Am J Med Genet A. 2016;170:1938\u201341.","DOI":"10.1002\/ajmg.a.37679"},{"key":"865_CR10","doi-asserted-by":"crossref","unstructured":"Inoue T, Yagasaki H, Nishioka J, Nakamura A, Matsubara K, Narumi S, et al. Molecular and clinical analyses of two patients with UPD(16)mat detected by screening 94 patients with Silver-Russell syndrome phenotype of unknown aetiology. J Med Genet. 2019;56:413\u20138.","DOI":"10.1136\/jmedgenet-2018-105463"},{"key":"865_CR11","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","DOI":"10.1038\/gim.2015.30"},{"key":"865_CR12","doi-asserted-by":"crossref","unstructured":"Masunaga Y, Inoue T, Yamoto K, Fujisawa Y, Sato Y, Kawashima-Sonoyama Y, et al. IGF2 mutations: report of five cases, review of the literature, and comparison with H19\/IGF2:IG-DMR epimutations. J Clin Endocrinol Metab. 2020;105:116\u201325.","DOI":"10.1210\/clinem\/dgz034"},{"key":"865_CR13","unstructured":"Genome Aggregation Database. http:\/\/gnomad.broadinstitute.org. Accessed 5 Mar 2020."},{"key":"865_CR14","unstructured":"Human Genetic Variation Database. http:\/\/www.hgvd.genome.med.kyoto-u.ac.jp. Accessed 5 Mar 2020."},{"key":"865_CR15","unstructured":"4.7KJPN, allele and genotype frequency panel from 4.7 K Japanese individuals. https:\/\/jmorp.megabank.tohoku.ac.jp. Accessed 5 Mar 2020."},{"key":"865_CR16","unstructured":"CADD (Combined Annotation Dependent Depletion). http:\/\/cadd.gs.washington.edu\/score. Accessed 5 Mar 2020."},{"key":"865_CR17","unstructured":"MutationTaster. http:\/\/www.mutationtaster.org. Accessed 5 Mar 2020."},{"key":"865_CR18","unstructured":"SIFT (Sorting Intolerant From Tolerant). https:\/\/sift.bii.a-star.edu.sg. Accessed 5 Mar 2020."},{"key":"865_CR19","unstructured":"PolyPhen-2 (HumVar). http:\/\/genetics.bwh.harvard.edu\/pph2. Accessed 5 Mar 2020."},{"key":"865_CR20","unstructured":"M-CAP (Mendelian Clinically Applicable Pathogenicity). http:\/\/bejerano.stanford.edu\/mcap. Accessed 5 Mar 2020."},{"key":"865_CR21","doi-asserted-by":"crossref","unstructured":"Lam WW, Hatada I, Ohishi S, Mukai T, Joyce JA, Cole TR, et al. Analysis of\u00a0germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype\u00a0correlation. J Med Genet. 1999;36:518\u201323.","DOI":"10.1136\/jmg.36.7.518"},{"key":"865_CR22","doi-asserted-by":"crossref","unstructured":"O'Dell SD, Day IN. Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol. 1998;30:767\u201371.","DOI":"10.1016\/S1357-2725(98)00048-X"},{"key":"865_CR23","doi-asserted-by":"crossref","unstructured":"Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B,\u00a0et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe\u00a0syndrome. Nat Genet. 2012;44:788\u201392.","DOI":"10.1038\/ng.2275"},{"key":"865_CR24","doi-asserted-by":"crossref","unstructured":"Avila M, Dyment DA, Sagen JV, St-Onge J, Moog U, Chung BHY, et al.\u00a0Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward\u00a0recommendation for molecular testing and management. Clin Genet.\u00a02016;89:501\u20136.","DOI":"10.1111\/cge.12688"},{"key":"865_CR25","doi-asserted-by":"crossref","unstructured":"Nikkel SM, Dauber A, de Munnik S, Connolly M, Hood RL, Caluseriu O, et al.\u00a0The phenotype of Floating-Harbor syndrome: clinical characterization of 52\u00a0individuals with mutations in exon 34 of SRCAP. Orphanet J Rare Dis.\u00a02013;8:63.","DOI":"10.1186\/1750-1172-8-63"},{"key":"865_CR26","doi-asserted-by":"crossref","unstructured":"Zollino M, Zweier C, Van Balkom ID, Sweetser DA, Alaimo J, Bijlsma EK, et al.\u00a0Diagnosis and management in Pitt-Hopkins syndrome: first international\u00a0consensus statement. Clin Genet. 2019;95:462\u201378.","DOI":"10.1111\/cge.13506"},{"key":"865_CR27","doi-asserted-by":"crossref","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al.\u00a0Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2,\u00a0cause Noonan syndrome. Nat Genet. 2001;29:465\u20138.","DOI":"10.1038\/ng772"},{"key":"865_CR28","doi-asserted-by":"crossref","unstructured":"Walenkamp MJE, Robers JML, Wit JM, Zandwijken GRJ, van Duyvenvoorde\u00a0HA, Oostdijk W, et al. Phenotypic features and response to GH treatment of\u00a0patients with a molecular defect of the IGF-1 receptor. J Clin Endocrinol\u00a0Metab. 2019;104:3157\u201371.","DOI":"10.1210\/jc.2018-02065"},{"key":"865_CR29","doi-asserted-by":"crossref","unstructured":"Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, et al.\u00a0Standardized centile curves and reference intervals of serum insulin-like\u00a0growth factor-I (IGF-I) levels in a normal Japanese population using the LMS\u00a0method. Endocr J. 2012;59:771\u201380.","DOI":"10.1507\/endocrj.EJ12-0110"},{"key":"865_CR30","doi-asserted-by":"crossref","unstructured":"Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, et al.\u00a0Noonan syndrome: clinical features, diagnosis, and management guidelines.\u00a0Pediatrics. 2010;126:746\u201359.","DOI":"10.1542\/peds.2009-3207"},{"key":"865_CR31","doi-asserted-by":"crossref","unstructured":"Meyer R, Soellner L, Begemann M, Dicks S, Fekete G, Rahner N, et al.\u00a0Targeted next generation sequencing approach in patients referred for Silver-Russell syndrome testing increases the mutation detection rate and\u00a0provides decisive information for clinical management. J Pediatr.\u00a02017;187:206\u201312.","DOI":"10.1016\/j.jpeds.2017.04.018"},{"key":"865_CR32","doi-asserted-by":"crossref","unstructured":"Neuheuser L, Meyer R, Begemann M, Elbracht M, Eggermann T. Next\u00a0generation sequencing and imprinting disorders: current applications and\u00a0future perspectives: Lessons from Silver-Russell syndrome. Mol Cell Probes.\u00a02019;44:1\u20137.","DOI":"10.1016\/j.mcp.2018.12.007"},{"key":"865_CR33","doi-asserted-by":"crossref","unstructured":"Brioude F, Oliver-Petit I, Blaise A, Praz F, Rossignol S, Le Jule M, et al.\u00a0CDKN1C mutation affecting the PCNA-binding domain as a cause of familial\u00a0Russell Silver syndrome. J Med Genet. 2013;50:823\u201330.","DOI":"10.1136\/jmedgenet-2013-101691"},{"key":"865_CR34","doi-asserted-by":"crossref","unstructured":"Sabir AH, Ryan G, Mohammed Z, Kirk J, Kiely N, Thyagarajan M, et al. Familial\u00a0Russell-Silver syndrome like phenotype in the PCNA domain of the CDKN1C\u00a0gene, a further case. Case Rep Genet. 2019;1398250.","DOI":"10.1155\/2019\/1398250"},{"key":"865_CR35","doi-asserted-by":"crossref","unstructured":"Giabicani E, Willems M, Steunou V, Chantot-Bastaraud S, Thibaud N, Abi\u00a0Habib W, et al. Increasing knowledge in IGF1R defects: lessons from 35 new\u00a0patients. J Med Genet. 2020;57:160\u20138.","DOI":"10.1136\/jmedgenet-2019-106328"},{"key":"865_CR36","doi-asserted-by":"crossref","unstructured":"Milani D, Scuvera G, Gatti M, Tolva G, Bonarrigo F, Esposito S, et al. Perthes\u00a0disease: a new finding in Floating-Harbor syndrome. Am J Med Genet A.\u00a02018;176:703\u20136.","DOI":"10.1002\/ajmg.a.38605"},{"key":"865_CR37","doi-asserted-by":"crossref","unstructured":"Menzies L, D'Arco F, Ganesan V, Hurst JA. Intracranial vascular pathology in\u00a0two further patients with Floating-Harbor syndrome: proposals for\u00a0cerebrovascular disease risk management. Eur J Med Genet.\u00a02020;63:103785.","DOI":"10.1016\/j.ejmg.2019.103785"},{"key":"865_CR38","doi-asserted-by":"crossref","unstructured":"Wakeling EL, Amero SA, Alders M, Bliek J, Forsythe E, Kumar S, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet. 2010;47:760\u20138.","DOI":"10.1136\/jmg.2010.079111"},{"key":"865_CR39","doi-asserted-by":"crossref","unstructured":"Wang SR, Carmichael H, Andrew SF, Miller TC, Moon JE, Derr MA, et al. Large-scale pooled next-generation sequencing of 1077 genes to identify genetic causes of short stature. J Clin Endocrinol Metab. 2013;98:E1428\u201337.","DOI":"10.1210\/jc.2013-1534"},{"key":"865_CR40","doi-asserted-by":"crossref","unstructured":"Kagami M, Mizuno S, Matsubara K, Nakabayashi K, Sano S, Fuke T, et al. Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell syndrome-compatible phenotype. Eur J Hum Genet. 2015;23:1062\u20137.","DOI":"10.1038\/ejhg.2014.234"},{"key":"865_CR41","doi-asserted-by":"crossref","unstructured":"Fukawatase Y, Toyoda M, Okamura K, Nakamura K, Nakabayashi K, Takada S, et al. Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability. Sci Rep. 2014;4:5421.","DOI":"10.1038\/srep05421"},{"key":"865_CR42","doi-asserted-by":"crossref","unstructured":"Shima H, Koehler K, Nomura Y, Sugimoto K, Satoh A, Ogata T, et al. Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations. J Med Genet. 2018;55:81\u20135.","DOI":"10.1136\/jmedgenet-2017-105020"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00865-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T17:02:59Z","timestamp":1666976579000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00865-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00865-x","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"8 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board Committee at the National Center for Child Health and Development (committee\u2019s reference number: 518) and performed after obtaining written informed consent to participate in this study from the patients or the patients\u2019 parents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained written informed consent from the patients or the patients\u2019 parents to publish patients\u2019 clinical and molecular information as well as facial photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}